Mid-term review of the EU/ACP/WHO Renewed Partnership for strengthening pharmaceutical systems and improving access to quality medicines in 15 African ACP Countries

The “The Renewed EU/ACP/WHO Partnership” (RP) was a four year programme (October 2012 – September 2016) with the overall objective to contribute to the achievement of health related MDGs and to universal health coverage in African ACP countries by improving availability, affordability and use of safe, effective and quality assured essential medicines for the treatment of priority acute and non-communicable diseases. The programme budget was EUR 10.8 million. The RP programme design included a number of guiding principles: a focus on Health System Strengthening (HSS); ownership by beneficiaries; catalytic funding; and promotion of inter-country and South-South collaboration. It was implemented in 15 African countries.

A mid-term review (MTR) took place at the beginning of the third year of this project with the objective to assess the partnership implementation progress and achievements considering relevance, effectiveness and efficiency; draw lessons learnt; and producing recommendations for both, the second part of the partnership and an eventual new partnership in the future.